Latest news with #Rosen
New York Post
10-07-2025
- Health
- New York Post
Bizarre viral migraine hack can really work, says neurologist — here's how
Heads up, bottles up. Worldwide, more than 1 billion people suffer from migraines — and because the cause isn't fully understood, treating them can be tricky, with suffers often curling up in a dark, quiet room, waiting for the pain to pass. But one young woman has revealed the bizarre, unlikely hack that works for her — even when pain meds don't. Advertisement And a neurologist told The Post her method actually makes sense. 3 In a viral video, Tilly Walker revealed that she balances a bottle on her forehead to fight migraines. TikTok/@toeatilly In a viral video, Tilly Walker (@toeatilly) lies in bed, face up, while balancing a full bottle of Evian water on her forehead. 'How I sleep, as no medicine helps my migraines, but balancing a water bottle on my head stops the pain,' she explained. Advertisement She said figuring it out has been 'life-changing knowledge.' While this basic balancing act may seem like too simple a solution, experts say there's science to support it. 'There is a long history of using pressure on the forehead to relieve pain, from placing stones on the body to tying a handkerchief tight on the head,' Noah Rosen, MD, a neurologist and director of the Northwell Headache Center, told The Post. Advertisement 'Some of the benefits from this may be Diffuse Noxious Inhibitory Control (or DNIC), where a strong stimulus may suppress another one, like rubbing around a paper cut. 'There have even been devices like the Nerivio patch, which try to use a stimulus on the arm to reduce headaches.' 3 While there is no known cure for the menace that is a migraine, the internet is rife with remedies. Getty Images Advertisement For Tilly, the pressure is key — she noted that the bottle has to be full for it to work. And commenters have pointed out how absolutely desperate she must have been when she stumbled upon the trick. 'This is the sort of thing that only a person with a migraine could think of trying,' wrote one. But she's not alone — several commenters have admitted to using the water bottle method as well. 'GIRL!!! I thought I was the only one doing it, it works so well,' one said. Rosen noted that the bottle may also function as a mindfulness tool, offering further relief.. 3 Rosen notes that the bottle may also function as a mindfulness tool. licvin – Advertisement 'Focusing on the bottle rather than the pain may help to be in the moment rather than focusing on a discomforting abstraction,' he explained. Other commenters have chimed in to share their own weird recommendations for alleviating a severe headache, including consuming raw mimosa flowers, wearing an eye mask, applying potato slices to the forehead, submerging feet in hot water, and getting a daith or inner ear piercing. Other cures include the viral 'migraine meal,' which consists of a large Coca-Cola and a large order of fries from McDonald's. One viral video — with more than 3.8 million views — shows a girl at the fast-food chain's drive-thru with overlay text reading, 'Trying McDonald's chips [fries] and a Diet Coke because I've had a headache for 48 hours and TikTok said it would help.' Advertisement Doctors say the caffeine in soda can operate as a nerve disruptor, a substance that affects nerve activity and blood flow to the brain. Sometimes, this disturbance works positively, but it's a roll of the dice or a draw of the straw, as caffeine consumption can also trigger migraines. In addition, the salt and sugar present in the 'migraine meal' can constrict blood vessels and also impact blood flow to the brain. Advertisement Aside from fast food, experts have seen success in using magnesium to prevent migraines. For his part, Rosen says the water bottle hack is a generally safe choice for migraine sufferers so long as they take precautions. 'I would say if you do it, be careful and don't let it hurt your eyes, nose or spill on you!'
Miami Herald
09-07-2025
- Miami Herald
Cop sexually assaulted teen sisters he met at youth program years ago, CA police say
A veteran police officer has been charged after two sisters accused him of sexually assaulting them more than a decade ago, California police say. Saul Duran was arrested July 7 on 'multiple felony charges related to the sexual assault of a minor,' the San Jose Police Department said in a July 8 news release. 'We were devastated to learn of these allegations and we hope that our swift investigation and arrest of Duran will demonstrate to survivors that we will treat your disclosure seriously, regardless of how much time has passed,' Chief of Police Paul Joseph said in the release. 'If the violator is a police officer, they will not be protected by other police officers.' Two adult sisters came to police June 18 and accused Duran of sex crimes between 2008 and 2012 when they were minors, police said. Through an investigation, police said they learned Duran met the sisters, ages 14 and 15, while he volunteered as 'a facilitator in a Santa Clara County District Attorney's Office program, known as The Parent Project.' The project is aimed to benefit 'parents with difficult or out-of-control adolescents,' teaching them 'prevention and intervention strategies for destructive behaviors,' according to the program's website. Duran worked as a volunteer with the program but 'served in an official capacity as a police officer,' police said. The girls' mother thought of him 'as a positive influence' and gained her trust, police said. She allowed her daughters to meet with him 'outside the scope of the program,' violating the program's policies, according to police. 'It was during these unauthorized and unsupervised interactions that the alleged crimes occurred,' according to police. Duran, who was hired by the department in 2003, 'was placed on administrative leave pending the outcome of both a criminal and internal administrative investigation,' according to KTVU and police. Police said they worked with the Santa Clara County District Attorney's Office, which 'determined there was sufficient basis for criminal prosecution.' During a news conference, Santa Clara County District Attorney Jeff Rosen said that while Duran is accused of sexually assaulting both girls, the statute of limitations only allowed for charges to be filed in the younger sister's case, KQED reported. Rosen said Duran was 'charged with five counts of lewd and lascivious acts on a child who is 14 or 15 years old,' the radio station reported. 'Sometimes, parents abuse children. Sometimes it's teachers or coaches. Sometimes a police officer. It might seem like this happens so much, but statistically these are still aberrations,' Rosen said in the release. 'The SJPD and the DA's Office are here to deal with criminal aberrations, to try and prevent them, and make sure that predators – like this one – stop and pay for what they have done.' Duran was released from jail after posting $250,000 bail and is scheduled to appear in court for arraignment Aug. 7, KPIX reported. Police said there may be additional victims and anyone with information is asked to contact them at 408-277-4082.
Business Wire
01-07-2025
- Health
- Business Wire
Northwell's Dr. Stacey E. Rosen assumes American Heart Association presidency
NEW HYDE PARK, N.Y.--(BUSINESS WIRE)--A fierce advocate for women's heart health and an active volunteer with the American Heart Association for over three decades, Northwell Health's Stacey E. Rosen, MD, senior vice president of women's health and executive director of the Katz Institute for Women's Health (KIWH), has begun her term as the organization's 2025-2026 volunteer president. The American Heart Association is the world's leading nonprofit organization focused on heart and brain health. As the president, Dr. Rosen, a practicing cardiologist for over 30 years, serves as the lead volunteer scientific and medical officer of the organization. She will use her presidency to continue to champion health and hope for everyone, everywhere. 'I am honored to have the opportunity to serve as the next volunteer president of the American Heart Association as this extraordinary organization begins its 101 st year of operation. My vision for this term is to build on the Association's incredible legacy with a focus on scientific discovery that improves the lives of all people, advancing systems of care and policy that are accessible and promoting healthy lifestyles to improve health outcomes,' said Dr. Rosen. 'Together, with the more than 35 million volunteers and supporters of the Association nationwide, and the organization's staff, we will continue to be a relentless force for a world of longer and healthier lives.' As volunteer president of the American Heart Association, Dr. Rosen will share insights to help guide the strategic direction of various Association committees. She will serve as: chair of the Science Advisory & Coordinating Committee; and as a member of the Executive Committee, Governance Committee, Corporate Operations Coordinating Committee, Compensation, Benefits and Human Resources Committee, and International Committee. 'Northwell is immensely proud of Dr. Rosen's appointment as president of the American Heart Association. Her tireless dedication to women's heart health and decades of service make her the perfect advocate to lead this vital organization,' said Michael Dowling, president and CEO of Northwell Health. 'During her tenure, we know she'll continue to make an even more of a profound difference in the lives of countless individuals and families.' As a passionate volunteer, she has offered her time, clinical expertise and advocacy to advance the mission of the Association. Dr. Rosen has served in leadership roles at the local, regional and national levels, including the National Board of Directors. With a career focused on the cardiovascular health of women, Dr. Rosen is engaged in the Association's Go Red for Women™ initiative. In 2018, Dr. Rosen received the American Heart Association's Women in Cardiology Mentoring Award; and in 2021, she received its Physician of the Year Award. Dr. Rosen oversees Northwell's Katz Institute for Women's Health. Its mission is to improve the health of women throughout their lives, bridging the gap between wellness and personalized care delivery. With a dedicated focus on women, the Katz Institute offers a comprehensive approach and sets the standards for excellence in patient-centered women's healthcare. It also serves as a convener and amplifier for all of Northwell's women's health initiatives, including supporting sex- and gender-specific research, providing expert, coordinated clinical care, and educating the community on prevention and well-being. She is a highly sought-after expert in cardiology and women's health, frequently recognized for her accomplishments. In 2025, she and her colleague, Jennifer H. Mieres, MD received the American Medical Women's Association (AMWA) Lila A. Wallis Women's Health Award. In 2024, she was named one of Modern Healthcare's 50 Most Influential Clinical Executives and one of Reuters Events' Trailblazing Women in Healthcare. The previous year, 2023, she received the WomenHeart Wenger Award for Excellence in Medical Advocacy. Dr. Rosen co-authored the book Heart Smarter for Women: Six Weeks to a Healthier Heart (2022) and co-produced the documentary Ms. Diagnosed, which premiered at the Cinequest film festival in 2020. About Northwell Health Northwell is the largest not-for-profit health system in the Northeast, serving residents of New York and Connecticut with 28 hospitals, more than 1,000 outpatient facilities, 22,000 nurses and over 20,000 physicians. Northwell cares for more than three million people annually in the New York metro area, including Long Island, the Hudson Valley, western Connecticut and beyond, thanks to philanthropic support from our communities. Northwell is New York State's largest private employer with over 104,000 employees – including members of Northwell Health Physician Partners and Nuvance Health Medical Practices – who are working to change health care for the better. Northwell is making breakthroughs in medicine at the Feinstein Institutes for Medical Research. Northwell is training the next generation of medical professionals at the visionary Donald and Barbara Zucker School of Medicine at Hofstra/Northwell and the Hofstra Northwell School of Nursing and Physician Assistant Studies. For information on our more than 100 medical specialties, visit and follow us @NorthwellHealth on Facebook, X, Instagram and LinkedIn.
Business Wire
26-06-2025
- Business
- Business Wire
QIAGEN Announces Election of Stephen Rusckowski as Chairman of Supervisory Board
VENLO, Netherlands--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that its Supervisory Board has elected Stephen H. Rusckowski as Chairman following the Annual General Meeting of Shareholders (AGM) on June 26, 2025. He succeeds Lawrence A. Rosen, who did not stand for re-election after serving for 12 years on the Supervisory Board. The Dutch Corporate Governance Code indicates that Directors of public companies should not serve more than 12 years for a company on their Supervisory Board. At the AGM, where 80.4% of QIAGEN's issued shares were represented, shareholders approved all proposed resolutions, including the initiation of an annual cash dividend and a new share repurchase authorization of up to $500 million. Mr. Rusckowski joined the Supervisory Board in 2023 and has served as Chairman of the Nomination & Governance Committee and as a member of the Human Resources & Compensation Committee. He brings deep global healthcare and leadership experience, having previously served as Chairman, President and CEO of Quest Diagnostics and as CEO of Philips Healthcare. Mr. Rusckowski said: 'QIAGEN has built an outstanding portfolio of solutions trusted for their quality and scientific excellence. What continues to impress me is the clear vision that drives this company: a commitment to making improvements in life possible. I take on this role with deep respect for QIAGEN, its culture and its people, and with a clear recognition of the Supervisory Board's responsibility to be a strong and engaged partner for shareholders and other stakeholders.' Mr. Rosen stepped down after serving as Chairman since 2020 and serving as a member of the Supervisory Board since 2013. Under his leadership, QIAGEN underwent a period of focused strategic transformation and strengthened governance. Five new members have joined the Supervisory Board since 2020, enhancing its already strong international profile and deep expertise. 'It has been an extraordinary privilege to serve QIAGEN through a period of meaningful transformation and growth, and I believe QIAGEN has never been in a stronger position,' Mr. Rosen said. 'I will very much enjoy watching the progress as the employees of QIAGEN do great things to help our customers advance science and improve healthcare for people around the world.' Additionally, Prof. Dr. Elaine Mardis stepped down from the Supervisory Board after deciding not to stand for re-election. Prof. Dr. Mardis brought important scientific expertise to the Board since 2014, especially through her service on the Science & Technology and Human Resources & Compensation Committees. Following the AGM, QIAGEN's Supervisory Board now consists of eight members, reflecting the implementation of a plan announced in 2024 to return to a size consistent with historical levels and continuing to represent all the necessary expertise to support the future development of QIAGEN in a highly effective manner. The AGM approved the re-appointment for one-year terms of the following Board members: Dr. Metin Colpan, Dr. Toralf Haag, Prof. Dr. Ross L. Levine, Mr. Bert van Meurs, Ms. Eva van Pelt, Dr. Eva Pisa, Ms. Elizabeth Tallett and Mr. Stephen H. Rusckowski. Shareholders also approved the initiation of QIAGEN's first-ever annual cash dividend - a milestone that reflects QIAGEN's strong financial position and disciplined capital allocation strategy, which includes dividends in addition to organic investments, value-creating acquisitions and share repurchases. The first dividend payment will be $0.25 per ordinary share, totaling approximately $54 million, with a record and ex-date of July 2, 2025, and payment date of July 10, 2025. In addition, the AGM approved a new synthetic share repurchase authorization of up to $500 million, reinforcing QIAGEN's commitment to returning capital to shareholders while preserving financial flexibility to invest in innovation and long-term growth. About QIAGEN QIAGEN N.V., a Netherlands-based holding company, is the leading global provider of Sample to Insight solutions, enabling customers to extract and gain valuable molecular insights from samples containing the building blocks of life. Our sample technologies isolate and process DNA, RNA and proteins from blood, tissue and other materials. Assay technologies prepare these biomolecules for analysis while bioinformatics software and knowledge bases can be used to interpret data to find actionable insights. Automation solutions bring these processes together into seamless and cost-effective workflows. QIAGEN serves over 500,000 customers globally in Life Sciences (academia, pharma R&D and industrial applications, primarily forensics) and Molecular Diagnostics for clinical healthcare. As of March 31, 2025, QIAGEN employed more than 5,600 people in over 35 locations worldwide. For more information, visit Forward-Looking Statement Certain statements in this press release may constitute forward-looking statements within the meaning of Section 27A of the U.S. Securities Act of 1933, as amended, and Section 21E of the U.S. Securities Exchange Act of 1934, as amended. These statements, including those regarding QIAGEN's products, development timelines, marketing and / or regulatory approvals, financial and operational outlook, growth strategies, collaborations and operating results - such as expected adjusted net sales and adjusted diluted earnings - are based on current expectations and assumptions. However, they involve uncertainties and risks. These risks include, but are not limited to, challenges in managing growth and international operations (including the effects of currency fluctuations, regulatory processes and logistical dependencies), variability in operating results, commercial development for our products to customers in the Life Sciences and clinical healthcare, changes in relationships with customers, suppliers or strategic partners; competition and rapid technological advancements; fluctuating demand for QIAGEN's products due to factors such as economic conditions, customer budgets and funding cycles; obtaining and maintaining regulatory approvals for our products; difficulties in successfully adapting QIAGEN's products into integrated solutions and producing these products; and protecting product differentiation from competitors. Additional uncertainties may arise from market acceptance of new products, integration of acquisitions, governmental actions, global or regional economic developments, natural disasters, political or public health crises, and other "force majeure" events. There is also no guarantee that anticipated benefits from restructuring programs and acquisitions will materialize as expected. For a comprehensive overview of risks, please refer to the 'Risk Factors' contained in our most recent Annual Report on Form 20-F and other reports filed with or furnished to the U.S. Securities and Exchange Commission. Source: QIAGEN N.V.
CNN
24-06-2025
- Business
- CNN
A grocery store staple is getting a major makeover
King's Hawaiian, maker of sweet buns and rolls that come in distinct bright-orange packaging, is retooling its branding as part of its 75th anniversary. The company unveiled Tuesday a modernized logo and updated packaging for its products, which have grown in recent years to include snacks like pretzel bites and cinnamon rolls. King's Hawaiian introduced the crown logo on its packaging in 2018, with a capital serif font. The new logo is softer and friendlier: The crown is now rounded, and the brand name is written in a hand-drawn font that is 'cushier,' resembling its trademark rolls, according to King's Hawaiian chief marketing officer Raouf Moussa. 'We're not making a left turn or doing a drastic revolution — it's more of an evolution and modernizing our brand expression,' Moussa told CNN. However, the company was careful not to lose the personality of the bright packaging that helps King's Hawaiian stand out in bread aisles. The orange color is now warmer and includes a new motif inspired by native Hawaiian flowers and meant to resemble a gift. 'Obviously, (the orange) is what we're known for and have established for a long, long time, so we're not losing that,' Moussa said. 'We're just slightly adjusting it, making it a little warmer.' The changes come at a challenging time for grocery sales and this category in particular. Consumers are looking to cut back their grocery spending and shift away from name brands to more affordable private-label options. Bread and rolls sales have declined by nearly 1% in the past year, according to market research firm Circana. Moussa said King's sales have grown year-over-year, however. Consumer packaged goods expert Nate Rosen said that's likely because its brand identity hasn't swayed too far from its original positioning of selling sweetly flavored rolls and buns. 'They're not trying to reinvent themselves every five minutes, which is honestly refreshing,' Rosen told CNN. 'When you bite into one of those rolls you immediately know what it is.' Rosen, who writes the Express Checkout newsletter, said King's Hawaiian expansion and refresh is an 'update to keep things slightly modern and eye-catching while staying grounded in what made them successful.' Still, King's Hawaiian has been rolling out new products and advertising strategies. Last year, the company debuted television ads with former NFL quarterbacks Peyton and Eli Manning that promoted sliders and pretzel bites. It's also planning to show off the new branding during an upcoming NASCAR race with the company's partner Joe Gibbs Racing. The company also created a new 'Bites' line when launching with miniature-sized salted soft pretzel bites. The line was inspired by feedback in recent years from consumers who said they're are snacking on the rolls rather than using them for sandwiches. The Bites line has been a 'tremendous success from the get-go,' Moussa said. The company plans to expand Bites, likely with miniature cinnamon rolls that are being tested in California and are selling 'slightly better' than their pretzel bites.
